Meeting the New AACP Competencies in Genetics and Clinical Pharmacogenomics at the University of Minnesota

Objective: Pharmacogenomics (PGx) is increasingly being used for creating individualized treatments for patient care. Healthcare professionals, especially pharmacists, need to understand how genetic variation impacts the efficacy and toxicity of medications. Due to the breadth and complexity of PGx-...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacob Brown (Author), Lindsay A Sorge (Author), William S Oetting (Author), Pamala A Jacobson (Author), Chrystian Pereira (Author)
Format: Book
Published: University of Minnesota Libraries Publishing, 2024-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d0aa5d48d091408b8775ae973f6f471b
042 |a dc 
100 1 0 |a Jacob Brown  |e author 
700 1 0 |a Lindsay A Sorge  |e author 
700 1 0 |a William S Oetting  |e author 
700 1 0 |a Pamala A Jacobson  |e author 
700 1 0 |a Chrystian Pereira  |e author 
245 0 0 |a Meeting the New AACP Competencies in Genetics and Clinical Pharmacogenomics at the University of Minnesota  
260 |b University of Minnesota Libraries Publishing,   |c 2024-02-01T00:00:00Z. 
500 |a 10.24926/iip.v14i4.5142 
500 |a 2155-0417 
520 |a Objective: Pharmacogenomics (PGx) is increasingly being used for creating individualized treatments for patient care. Healthcare professionals, especially pharmacists, need to understand how genetic variation impacts the efficacy and toxicity of medications. Due to the breadth and complexity of PGx-related information, it has been challenging to determine what information should be included in pharmacy curricula and how best to educate students. Methods: The University of Minnesota College of Pharmacy recently began the process of incorporating into the curriculum expanded competencies for PGx from the American Association of Colleges of Pharmacy (AACP) Pharmacogenomics Special Interest Group (PGx-SIG). We evaluated our curriculum for PGx content, determined what was currently being taught and identified educational gaps.  Results: A review of our Doctor of Pharmacy curriculum showed substantial PGx content, although it was inconsistently taught throughout the required courses and in some courses absent. We revised the content of existing courses incorporating content that meet most of the PGx-SIG recommended competencies.  Conclusion: There are and will be major changes in our understanding of the influences of PGx on individualized medical treatment.  As our understanding grows, information on PGx in pharmacy curriculums will need to keep pace with these changes. We have begun this process at the University of Minnesota by doing a full review of PGx related information and making appropriate revisions in the pharmacy curriculum. 
546 |a EN 
690 |a Pharmacogenomics 
690 |a Pharmacy Curricula 
690 |a Competencies 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n INNOVATIONS in Pharmacy, Vol 14, Iss 4 (2024) 
787 0 |n https://pubs.lib.umn.edu/index.php/innovations/article/view/5142 
787 0 |n https://doaj.org/toc/2155-0417 
856 4 1 |u https://doaj.org/article/d0aa5d48d091408b8775ae973f6f471b  |z Connect to this object online.